missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18201899

Insulin R/CD220 Antibody (83-7), HRP, Novus Biologicals™

Rabbit Monoclonal Antibody

Brand:  Novus Biologicals NBP2-81039H

Product Code. 18201899

  • 583.00 EUR / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Insulin R/CD220 Monoclonal specifically detects Insulin R/CD220 in Human samples. It is validated for ELISA, Immunohistochemistry, Immunohistochemistry-Paraffin.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Insulin R/CD220
Monoclonal
HRP
PBS
INSR
Epitope within amino acids 140-301 (the cysteine rich region) of the extracellular domain of the human Insulin R/CD220.
0.1 mL
Diabetes Research, Lipid and Metabolism, Neuroscience, Phospho Specific, Protein Kinase, Signal Transduction, Tyrosine Kinases
3643
Human
Purified
ELISA, Immunohistochemistry, Immunohistochemistry (Paraffin)
83-7
ELISA, Immunohistochemistry, Immunohistochemistry-Paraffin
CD 220, CD220, CD220 antigen, EC 2.7.10, EC 2.7.10.1, HHF5, insulin receptor, IR
Rabbit
Protein A purified
RUO
Primary
Recognises the extracellular domain of the Insulin R/CD220. Amino acids 469 - 592 (exon 7 and 8) of Insulin R/CD220.
Store at 4°C in the dark.
IgG κ
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.